3 Covid-19 Trials Have Been Paused for Safety. That’s a Good Thing.
October 15, 2020
NY Times Health | By 12:36 p.m. ET
Oct. 14, 2020,
Experts were comforted that companies are following safety precautions. They pointed out that pauses in vaccine trials are common, but pauses in treatment trials like Eli Lilly’s are rare. This week, two high-profile, late-stage clinical trials — Johnson & Johnson’s test of a coronavirus vaccine and Eli Lilly’s study of a Covid-19 drug — were put on pause because of possible safety concerns. Just a month earlier, AstraZeneca’s vaccine trial was paused after two volunteers became seriously ill. Read more…